Latest News

Glioblastoma patients treated with bevacizumab experience reduced cognitive function and quality of life, study suggests

Many glioblastoma patients treated with bevacizumab (AvastinŽ) have significant deterioration in neurocognitive function, symptoms and quality of life.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Stuck on you: Research shows fingerprint accuracy stays the same over time

  • Tamper-resistant opioids will not solve opioid addiction problem, study suggests

  • Huge congregations view racial inequality differently than others do, study shows

  • Children from high conflict homes process emotion differently, could face social challenges

  • Humans around the world dance to the same beat

  • Predicting which glioblastoma patients may benefit from drug treatment

  • When times are tough, parents favor daughters over sons

  • Key element of human language discovered in bird babble

  • How your brain knows it's summer

  • Specialized therapy can aid traumatized children in developing nations

  •